Immune to Cancer: The CRI Blog
-
Translating Cancer Immunotherapy Into COVID-19 Medicine
Investigators in CRI’s translational research program (CLIP) were quick to extend their cancer immunotherapy research into COVID-19…
-
Young Researchers Finding Answers to Cancer and COVID-19
Many CRI Irvington Postdoctoral Fellows pivoted their work, offered their expertise, volunteered their time, and have already…
-
How Cancer Immunotherapy Research Is Helping Us Confront COVID-19
CRI hosted esteemed immunologists Carl June, Miriam Merad, and E. John Wherry to highlight immunotherapy’s pivotal role…
-
Recapping ASCO20: The Next Horizons in Immunotherapy
The 56th Annual ASCO Meeting highlighted advances in checkpoint immunotherapy, cell-based immunotherapies, and bispecific antibodies.
-
ASCO20 Update: Cellular Immunotherapies, Genomics, and COVID-19
Several promising cellular immunotherapies were discussed at ASCO20, including those for solid cancers; plus updates on the cancer…
-
How COVID-19 is Impacting Care for Blood Cancer Patients
CRI spoke with Dr. Melody Smith about how clinical care for leukemia, lymphoma, and multiple myeloma patients…
-
How COVID-19 is Impacting Care for Lung Cancer Patients
CRI spoke with Dr. Joshua Sabari about how clinical care for lung cancer patients has been impacted…
-
Analytical Strategies in Immunology for Cancer and COVID-19 with Dr. Katie Campbell
Dr. Campbell’s work as a CRI fellow at UCLA is improving our understanding of both cancer and…
-
Cancer, COVID-19, and the Immune Genome with Dr. Brian Brown
CRI Technology Impact Award recipient Dr. Brian Brown has been developing a technology to help us better…